0001808220-24-000061.txt : 20240614 0001808220-24-000061.hdr.sgml : 20240614 20240614163338 ACCESSION NUMBER: 0001808220-24-000061 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240612 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GoHealth, Inc. CENTRAL INDEX KEY: 0001808220 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] ORGANIZATION NAME: 02 Finance IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39390 FILM NUMBER: 241045408 BUSINESS ADDRESS: STREET 1: 214 WEST HURON STREET CITY: CHICAGO STATE: IL ZIP: 60654 BUSINESS PHONE: (312) 386-8222 MAIL ADDRESS: STREET 1: 214 WEST HURON STREET CITY: CHICAGO STATE: IL ZIP: 60654 8-K 1 goco-20240612.htm 8-K goco-20240612
FALSE000180822000018082202024-06-122024-06-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 12, 2024
_________________________
GoHealth, Inc.
(Exact name of registrant as specified in its charter)
_________________________
Delaware001-3939085-0563805
(State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
222 W Merchandise Mart Plaza, Suite 175060654
Chicago,Illinois
(Address of principal executive offices)(Zip Code)
(312) 386-8200
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
_________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange
on which registered
Class A Common Stock,
$0.0001 par value per share
GOCOThe Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 12, 2024, GoHealth, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). The following are the voting results for the proposals considered and voted upon at the Annual Meeting, each of which was described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 26, 2024.

Proposal 1 — Election of three Class I directors for a term of office expiring on the date of the annual meeting of stockholders to be held in 2027 and until their respective successors have been duly elected and qualified.

Votes FORVotes WITHHELDBroker Non-Votes
Alexander Timm17,574,675399,9443,388,687
David Fisher17,334,868639,7513,388,687
Vijay Kotte17,823,710150,9093,388,687

Proposal 2 — Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024.

Votes FORVotes AGAINSTVotes ABSTAINEDBroker Non-Votes
21,315,29730,80017,2090

Proposal 3 — Approval, on an advisory basis, of the compensation of the Company’s named executive officers.

Votes FORVotes AGAINSTVotes ABSTAINEDBroker Non-Votes
17,612,402359,0873,1303,388,687

Based on the foregoing voting results, Alexander Timm, David Fisher, and Vijay Kotte were elected as Class I directors and Proposals 2 and 3 were approved.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GOHEALTH, INC.
Date:June 14, 2024By:/s/ Bradley M. Burd
Brad Burd
Chief Legal Officer

EX-101.SCH 2 goco-20240612.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 goco-20240612_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, State or Province Entity Address, State or Province Security Exchange Name Security Exchange Name Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cover [Abstract] Written Communications Written Communications Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security City Area Code City Area Code Document Period End Date Document Period End Date Amendment Flag Amendment Flag Entity Tax Identification Number Entity Tax Identification Number Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Pre-commencement Tender Offer Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 goco-20240612_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover
Jun. 12, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 12, 2024
Entity Registrant Name GoHealth, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39390
Entity Tax Identification Number 85-0563805
Entity Address, Address Line One 222 W Merchandise Mart Plaza, Suite 1750
Entity Address, City or Town Chicago,
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60654
City Area Code 312
Local Phone Number 386-8200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock,$0.0001 par value per share
Trading Symbol GOCO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001808220
Amendment Flag false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://www.gohealth.com/role/Cover Cover Cover 1 false false All Reports Book All Reports goco-20240612.htm goco-20240612.xsd goco-20240612_lab.xml goco-20240612_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "goco-20240612.htm": { "nsprefix": "goco", "nsuri": "http://www.gohealth.com/20240612", "dts": { "inline": { "local": [ "goco-20240612.htm" ] }, "schema": { "local": [ "goco-20240612.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd" ] }, "labelLink": { "local": [ "goco-20240612_lab.xml" ] }, "presentationLink": { "local": [ "goco-20240612_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 23 }, "report": { "R1": { "role": "http://www.gohealth.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "goco-20240612.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "goco-20240612.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.gohealth.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001808220-24-000061-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001808220-24-000061-xbrl.zip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end XML 16 goco-20240612_htm.xml IDEA: XBRL DOCUMENT 0001808220 2024-06-12 2024-06-12 false 0001808220 8-K 2024-06-12 GoHealth, Inc. DE 001-39390 85-0563805 222 W Merchandise Mart Plaza, Suite 1750 60654 Chicago, IL 312 386-8200 false false false false Class A Common Stock,$0.0001 par value per share GOCO NASDAQ false 2024-06-12